Contents
Download PDF
pdf Download XML
238 Views
126 Downloads
Share this article
Research Article | Volume 13 Issue:4 (, 2023) | Pages 946 - 951
“A Study On Serum Adenosine Deaminase as A Glycemic Indicator in Type 2 Diabetes Mellitus in A Tertiary Care Hospital”
Under a Creative Commons license
Open Access
Received
Sept. 10, 2023
Revised
Sept. 26, 2023
Accepted
Oct. 20, 2023
Published
Nov. 30, 2023
Abstract

Background: Diabetes mellitus (DM) is a chronic endocrine metabolic condition that is mainly avoidable and non-communicable, resulting in millions of deaths, crippling complications, and incalculable human anguish each year. It constantly exhibits three key abnormalities: resistance to insulin action in peripheral tissues, particularly muscle and adipose tissue, reduced insulin secretion, and increased glucose synthesis by the liver. Objectives: 1. To estimate the value of serum adenosine deaminase (ADA) in patients with uncomplicated type 2 diabetes mellitus through a Cross sectional study. 2. To determine any correlation exists between serum ADA and blood glucose values. Material & Methods: Study Design:  Hospital-based, cross sectional study. Study area: The study was conducted in the Department of General Medicine, Siddhartha medical college, Vijayawada. Study Period: September 2022 to August 2023. Study population: Individuals with uncomplicated type 2 diabetes mellitus including both male and female, of age group 30-70 years attending to the hospital. Sample size: Study consisted a total of 100 subjects. (50 cases and 50 controls). Study tools and Data collection procedure: A pre-structured and pre-tested proforma was used to collect the data. Informed consent was taken from all cases and control subjects. A detailed clinical history and physical examination was an integral part of the methodology. Relevant investigations (blood urea, serum creatinine, lipid profile, urine protein, ECG, Fundoscopy etc.) were done before selection of subjects for the study. For all the subjects standing height and weight were measured. BMI was calculated as per the formula: Weight (Kg)/Height(meters)2. Results: In the present study the mean ADA in study group is 40.60±8.65 and in the control group is 19.75±2.65. In the present study the mean FBS in study group is 172.24±76.47 and in the control group is 82.34±10.77. Conclusion: Serum levels of ADA were found to be significantly higher in type 2 diabetics when compared to controls. A very large correlation was found to exist between serum ADA and blood glucose values. Statistical association was found between serum ADA and the long term index of glycemic control, HbA1c. Body Mass Index, Age, Sex, duration of diabetes was not found to significantly influence the ADA level.

Keywords
Recommended Articles
Research Article
Effect of OM meditation on cardiovascular parameters in hypertensive patients
...
Published: 22/08/2025
Download PDF
Research Article
Endotracheal Size Estimation in Children: What is Latest? Different Methods and Correlation – A Prospective Observational Study
...
Published: 22/08/2025
Download PDF
Research Article
Mucocutaneous Manifestations of Human Immunodeficiency Virus Infection in Children
...
Published: 20/08/2025
Download PDF
Research Article
Influence of Ketogenic Diet on Gastric Functions, Motility, in Central Indian Subjects: A Case-Control Study on the
Published: 07/05/2024
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.